Literature DB >> 28231947

A New Epoch in Antitrypanosomal Treatment for Chagas Disease.

Caryn Bern1.   

Abstract

Entities:  

Keywords:  Chagas cardiomyopathy; Trypanasoma cruzi; benznidazole; intention-to-treat analysis; posaconazole; treatment failure

Mesh：

Substances：

Year:  2017        PMID： 28231947     DOI： 10.1016/j.jacc.2016.12.016

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  6 in total

1.  Genome-wide mutagenesis and multi-drug resistance in American trypanosomes induced by the front-line drug benznidazole.

Authors:  Mônica C Campos; Jody Phelan; Amanda F Francisco; Martin C Taylor; Michael D Lewis; Arnab Pain; Taane G Clark; John M Kelly
Journal:  Sci Rep       Date:  2017-10-31       Impact factor: 4.379

2.  Novel chemical starting points for drug discovery in leishmaniasis and Chagas disease.

Authors:  Irene Roquero; Juan Cantizani; Ignacio Cotillo; M Pilar Manzano; Albane Kessler; J Julio Martín; Case W McNamara
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2019-05-22       Impact factor: 4.077

Review 3.  Chagas Disease Infection Reactivation after Heart Transplant.

Authors:  Maria da Consolação Vieira Moreira; José Renan Cunha-Melo
Journal:  Trop Med Infect Dis       Date:  2020-06-29

Review 4.  Protozoan persister-like cells and drug treatment failure.

Authors:  Michael P Barrett; Dennis E Kyle; L David Sibley; Joshua B Radke; Rick L Tarleton
Journal:  Nat Rev Microbiol       Date:  2019-08-23       Impact factor: 60.633

5.  Beneficial effects of benznidazole in Chagas disease: NIH SaMi-Trop cohort study.

Authors:  Clareci Silva Cardoso; Antonio Luiz P Ribeiro; Claudia Di Lorenzo Oliveira; Lea Campos Oliveira; Ariela Mota Ferreira; Ana Luiza Bierrenbach; José Luiz Padilha Silva; Enrico Antonio Colosimo; João Eduardo Ferreira; Tzong-Hae Lee; Michael P Busch; Arthur Lawrence Reingold; Ester Cerdeira Sabino
Journal:  PLoS Negl Trop Dis       Date:  2018-11-01

Review 6.  Challenges in drug discovery targeting TriTryp diseases with an emphasis on leishmaniasis.

Authors:  Laura M Alcântara; Thalita C S Ferreira; Fernanda R Gadelha; Danilo C Miguel
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2018-09-28       Impact factor: 4.077
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.